BioNTech and Moderna, known for their COVID-19 mRNA vaccines, have been at the forefront of developing personalized cancer vaccines. Their approach involves sequencing a patient’s tumor genome, identifying the unique mutations, and then using mRNA technology to create a vaccine that instructs the body to target those specific cancer cells.